Persistence of itching in patients after scabies therapy: What to do?

Travel Med Infect Dis. 2023 Nov-Dec:56:102652. doi: 10.1016/j.tmaid.2023.102652. Epub 2023 Oct 12.

Authors

Cristian Fidanzi¹, Flavia Manzo Margiotta², Matteo Bevilacqua², Angelo Massimiliano D'Erme³, Giovanni Bagnoni³, Valentina Dini², Agata Janowska²

Affiliations

¹ Unit of Dermatology, University of Pisa, Pisa, Italy. Electronic address: cri.fidanzi@outlook.it.
² Unit of Dermatology, University of Pisa, Pisa, Italy.
³ Melanoma and Skin Cancer Unit AVNO (Area Vasta Nord Ovest) and Unit of Dermatology, Livorno Hospital, Livorno, Italy.

PMID: 37832709
DOI: 10.1016/j.tmaid.2023.102652

No abstract available

Keywords: Itching; Oral ivermectin; Scabies; Therapy.

Publication types

Letter

MeSH terms

Administration, Oral
Antiparasitic Agents / therapeutic use
Humans
Insecticides* / therapeutic use
Ivermectin / therapeutic use
Pruritus / drug therapy
Pruritus / etiology
Scabies* / drug therapy
Treatment Outcome

Substances

Ivermectin
Insecticides
Antiparasitic Agents